More on CVS Caremark's Q1


CVS Caremark (CVS) reports revenue in its Pharmacy Services segment rose 10.3% to $20.2B in Q1.

The Retail Pharmacy segment saw a 2.7% increase to $16.5B on a same-store sales gain of 1.4%.

Gross profit rate improved by 70 bps for the Retail Pharmacy segment and 40 bps for the Pharmacy Services segment.

A weaker flu season this year had an impact on the company's results.

From other sites
Comments (1)
  • Market DJ
    , contributor
    Comments (861) | Send Message
     
    WOW! Very impressive.... Not too many "pure" earnings beats for mega-caps in this market, except Disney.

     

    These are good numbers all the way around. I will be adding to my long $CVS position with any pullbacks :)

     

    Really, really good numbers, only getting better. Happy investing everyone!

     

    Long $CVS
    2 May 2014, 07:28 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs